Type Whole antibody Trade names Abegrin CAS Number 892553-42-3 | ATC code none | |
Target alpha-v beta-3 integrin | ||
Etaracizumab (also known as etaratuzumab, MEDI-522, trade name Abegrin) is a humanized monoclonal antibody which is being investigated for the treatment of metastatic melanoma, prostate cancer, ovarian cancer and various other types of cancer. It is manufactured by MedImmune.
References
Etaracizumab Wikipedia(Text) CC BY-SA